3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Kine Sciences Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 MAD Study of KINE-101 in Healthy Volunteers KINE-101, Placebo - Healthy Volunteers | Phase 1 | Completed | Kine Sciences Co., Ltd. | 24 | 2025-05-26 | 2026-01-07 |
| A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP KINE-101 - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 1 | Completed | Kine Sciences Co., Ltd. | 9 | 2024-08-27 | 2026-01-20 |
| A First-in-Human Study of KINE-101 in Healthy Volunteers KINE-101, Placebo - Healthy Volunteers | Phase 1 | Completed | Kine Sciences Co., Ltd. | 40 | 2021-11-05 | 2026-01-15 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
South Korea (2) · United States (1)
Hanna Park (3)